Brigham and Women’s Hospital will have a strong presence at this year’s American College of Cardiology (ACC) 2023 Scientific Session & Expo.
The ACC, together with the World Congress of Cardiology, will host the ACC.23/WCC event on March 4–6, 2023, in New Orleans, LA. There will also be a robust and engaging ACC.23/WCC virtual option for those who cannot attend in-person, with the ability to participate in real-time and on demand.
Experts from the Brigham’s Heart & Vascular Center will join thousands of international colleagues and present their latest research and clinical advancements, covering a wide range of topics in cardiovascular care with a global health perspective.
Learn more about the event and register here.
Brigham Participants
March 3, 2023
What’s Behind Causality in Atherothrombotic Events? Is It All About Triglycerides?
International ASCVD Risk Reduction Summit 2023
Peter Libby, MD: Co-Chair, Moderator and Speaker
March 4, 2023
Joint American College of Cardiology/Journal of the American College of Cardiology Late-Breaking Clinical Trials
Session 402, Great Hall: 9:30 a.m.
Michelle L O’Donoghue, MD, MPH, Panelist
Sex-specific Stress Perfusion Cardiac MRI in Suspected Ischemic Heart Disease: Analysis of the Multicenter Spins Registry
Session 1243, Poster Hall F: 10:45 a.m. – 11:30 a.m.
Bobby Heydari, MD; Yin Ge, MD; Panagiotis Antiochos, MD; Sabeeh Islam, MBBS; Kevin E. Steel, DO; Scott E. Bingham, MD; Shuaib Abdullah, MD; J. Ronald Mikolich, MD; Andrew E. Arai, MD; W. Patricia Bandettini, MD; Amit R. Patel, MD; Sujata Madhukar Shanbhag, MD; Afshin Farzaneh-Far, MD, PhD; John Heitner, MD; Chetan Shenoy, MD; Steven Leung, MD; Jorge A. Gonzalez, MD; Subha V. Raman, MD; Victor A. Ferrari, MD; Dipan J. Shah, MD; Jeanette Schulz-Menger, MD; Matthias Stuber, PhD; Orlando P. Simonetti, PhD; Raymond Y. Kwong, MD, MPH
Differences in Heart Failure-related Cardiogenic Shock Between Ischemic and Non-Ischemic Cardiomyopathy: Data From the Critical Care Cardiology Trials Network (CCCTN) Registry
Heart Failure and Cardiomyopathies: Clinical Science 2
Session 1245, Poster Hall F: 10:45 a.m.
Jason Feinman, MD
Reduction in Total Cardiovascular Events With the PCSK9 Inhibitor Evolocumab in Patients With Cardiovascular Disease in the Combined FOURIER and FOURIER Open-label Extension (OLE) Studies
Preventing Coronary Events: Diet, Inflammation, and the Air We Breathe
Session 1003, Poster Theater 7, Hall F: 11:00 a.m.
Sabina A. Murphy, MPH
Acute Kidney Injury and Outcomes in the Cardiac Intensive Care Unit: Insights From the Critical Care Cardiology Trials Network
Ischemic Heart Disease: Clinical Science 3
Session 1277, Poster Hall F: 11:45 a.m.
Sarma Singam, MD
Mixed Cardiogenic Shock: What, Why and How
Critical Care Cardiology Intensive I: Cardiogenic Shock – Featuring the 54th Annual Louis F. Bishop Keynote
Session 51, La Nouvelle B: 12:30 p.m.
David A. Morrow, MD, Speaker
Genetic Predisposition to Adiposity Is Associated With Greater Risk of Subsequent Heart Failure Events in Individuals With Type 2 Diabetes Mellitus
Diet, Physical Activity, Cardiac Rehab
Session 1020, Poster Theater 10, Hall F: 1:00 p.m.
Preclinical Evaluation of a Novel Solid Core Pressure Guidewire
Interventional and Structural: Coronary Interventions 5
Session 1342, Poster Hall F: 1:45 p.m.
NT-proBNP, Body Mass Index, and Heart Failure Risk in CAMELLIA-TIMI 61
Hot Topics in Heart Failure and Cardiomyopathies
Session 1030, Poster Theater 11, Hall F: 3:30 p.m.
Association of Baseline Lipoprotein(a) and Percentage of Lipoprotein(a) Lowering With Olpasiran
New Pharmacotherapeutics: Assessing Efficacy and Ensuring Safety
Session 1027, Poster Theater 7, Hall F: 3:15 p.m.
Michelle L O’Donoghue, MD, MPH
Cardiac Critical Care
FIT Forum: Mix and Mingle
Session 404, Mosaic Room: 5:30 p.m.
David A. Morrow, MD, Speaker
March 5, 2023
Cardiovascular Disease and LDL-Cholesterol: From WWII to Today: A Night of Science
Peter Libby, MD: Moderator
Highlighted Original Research in Congenital Heart Disease: Development and Validation of an Outcome Prediction Model for Repaired Tetralogy of Fallot, the Indicator Cohort
Presented by Dr. John Mayourain
Room 238: 8:00 a.m.
Trends and Factors Associated With Prophylactic Anticoagulation Strategies in COVID-19: An Analysis of the AHA COVID-19 CVD Registry
Highlighted Original Research: Vascular Medicine and the Year in Review
Session 905, Room 257: 8:36 a.m.
Should We Be Using Platelet Function/Genotyping? YES!
The Great DAPT Debates
Session 504, La Nouvelle C: 8:39 a.m.
Michelle L O’Donoghue, MD, MPH, Speaker
Highlighted Original Research: Ischemic Heart Disease and the Year in Review
Session 909, Room 219: 9:45 a.m.
Benjamin M. Scirica, MD, Co-Chair
Genetically Mediated Vascular Endothelial Cell Dysfunction and Its Dependence on Serum LDL Cholesterol Levels for the Development of Coronary Artery Atherosclerosis: Genetic Insights From the UKBB and FOURIER Trial
Innovative Technologies in the Management of Ischemic Heart Disease
Session 1039, Poster Theater 7, Hall F: 10:15 a.m.
Risk of Kidney Disease Progression and Efficacy of SGLT2 Inhibition in Patients With Type 2 Diabetes Mellitus
Prevention and Health Promotion: Diabetes and Cardiometabolic Disease 9
Session 1493, Poster Hall F: 10:45 a.m.
Relationship Between Cystatin C, Creatinine-based eGFR, Cardiovascular Events and Kidney Outcomes in DECLARE‑TIMI 58
Prevention and Health Promotion: Diabetes and Cardiometabolic Disease 9
Session 1493, Poster Hall F: 10:45 a.m.
Andre Small, MD
Prognostic Significance of Hemodynamic Parameters in Patients With Cardiogenic Shock
Heart Failure and Cardiomyopathies: Clinical Science 10
Session 1524, Poster Hall F: 11:45 a.m.
Hepatic Fat Changes After an Antisense Oligonucleotide Therapy Targeting ANGPTL3: A TRANSLATE-TIMI 70 Analysis
Prevention and Health Promotion: Lipids 10
Session 1525, Poster Hall F: 11:45 a.m.
André Zimerman, MD, PhD
Prognostic Implications of Various Myocardial Patterns of Ischemia and Infarction From 4,537 Contrast-enhanced Stress CMR Studies in Patients With Stable Chest Pain Syndromes: Analysis of ohe Multicenter Spins Registry
Session 1526, Poster Hall F: 11:45 a.m. – 12:30 p.m.
Sabeeh Islam, MBBS; Bobby Heydari, MD; Yin Ge, MD; Panagiotis Antiochos, MD; Kevin E. Steel, DO; Scott E. Bingham, MD; Shuaib Abdullah, MD; J. Ronald Mikolich, MD; Andrew E. Arai, MD; W. Patricia Bandettini, MD; Amit R. Patel, MD; Sujata Madhukar Shanbhag, MD; Afshin Farzaneh-Far, MD, PhD; John Heitner, MD; Chetan Shenoy, MD; Steve Leung, MD; Jorge A. Gonzalez, MD; Subha V. Raman, MD; Victor A. Ferrari, MD; Jeanette Schulz-Menger, MD; Orlando P. Simonetti, PhD; Matthias Stuber, PhD; Raymond Y. Kwong, MD, MPH
Stress Cardiovascular Magnetic Resonance Imaging Is an Effective Prognostic Tool in Patients With Suspected Ischemic Cardiomyopathy Regardless of Age, Sex, Race, Obesity, Hypertension, Diabetes, and LV Dilation
Session 1526, Poster Hall F: 11:45 a.m. – 12:30 p.m.
Saadia Qazi, DO; Yin Ge, MD; Krishna Patel, MD; Panagiotis Antiochos, MD; Sabeeh Islam, MBBS; Ryan B. Longmore, DO; Bobby Heydari, MD; Scott E. Bingham, MD; J. Ronald Mikolich, MD; Andrew E. Arai, MD; W. Patricia Bandettini, MD; Sujata Madhukar Shanbhag, MD; Amit R. Patel, MD; Afshin Farzaneh-Far, MD, PhD; John Heitner, MD; Chetan Shenoy, MD; Steve Leung, MD; Jorge A. Gonzalez, MD; Dipan J. Shah, MD; Subha V. Raman, MD; Victor A. Ferrari, MD; Jeanette Schulz-Menger, MD; Matthias Stuber, PhD; Orlando P. Simonetti, PhD; Raymond Y. Kwong, MD, MPH
Growth Differentiation Factor-15, Clinical Outcomes, and the Effect of Dapagliflozin in Patients With Heart Failure and Reduced Ejection Fraction: Insights From the DAPA-HF Trial
Heart Failure and Cardiomyopathies: Clinical Science 12
Session 1593, Poster Hall F: 1:45 p.m.
Renal Denervation and Novel Translational Vascular Research
Room 257: 2:00 p.m. – 3:15 p.m.
Laurel Lee MD, DPhil, Co-Chair
Late-Breaking Clinical Trials Deep Dive I
Session 408, Great Hall: 2:00 p.m.
Michelle L O’Donoghue, MD, MPH, Co-Chair
Blind Case Roulette Congenital Heart Faculty Under Fire
Room 228: 2:00 p.m.
Debate: Do Use DOAC in Mechanical Valves
Through Thick and Thin: Anticoagulation Agents in Valvular Heart Disease
Session 700, Room 221: 2:20 p.m.
Multimodality Imaging Approaches to ACS Presentations in Pregnancy
Imaging for Two: Cardiovascular Imaging in Pregnancy
Room 227: 4:30 p.m.
Advances in Nuclear Amyloid Imaging: Current for Diagnosis. Future for Guiding Treatment
The Cutting Edge Nuclear Lab in 2023: Joint Symposium of the American Society of Nuclear Cardiology and the American College of Cardiology
5:06 p.m.
March 6, 2023
Combined High-risk Plaque Variables Low Endothelial Shear Stress, High Endothelial Shear Stress Gradient and High Plaque Structural Stress Co-localize in Coronary Plaques Responsible for Major Adverse Cardiac Events
Mona Ahmed, MD, PhD
Clear as Mud: FDG-PET/CT, Nuances of Advanced Imaging
The Great Masquerader… Unmasking the Many Faces of Sarcoid
Session 714, Room 252: 8:30 a.m. – 9:45 a.m.
Leveraging Behavioral Science to Improve Patient Enrollment in a Remote Hypertension Management Program
Spotlight on Special Topics: Innovation, Digital Health, and Technology 15
Session 1707, Poster Hall F: 9:45 a.m.
Edoxaban 30 MG vs. Warfarin in 2,406 Patients Age ≥80 Years: A Randomized Analysis From ENGAGE AF-TIMI 48
Stroke Prevention in AF: Drugs and Devices
Session 1076, Poster Theater 8, Hall F: 10:30 a.m.
André Zimerman, MD, PhD
Debates in Stable Ischemic Heart Disease (SIHD): Translating New Guidelines, AUC, and Evidence Into Clinical Practice
Session n510, La Nouvelle C: 11:00 a.m.
Updates in Antithrombotic Strategies After PCI
Session 747, Room 209: 12:45 p.m.
Michelle L O’Donoghue, MD, MPH, Co-Chair
Arrhythmias in Unusual Cardiomyopathies
Session 742, Room 357: 12:45 p.m. – 2:00 p.m.
William H. Sauer, MD, and Neal K. Lakdawala, MD
2023 Eugene Braunwald Keynote
Session 412, Room 257: 1:30 p.m.
What Is the Role of Radionuclide Imaging?
Cardiac Amyloidosis in Real World Clinical Practice: Ready for Multimodality Imaging Standards!
2:54 p.m.
Date TBD
Growth Differentiation Factor-15, Clinical Outcomes, and the Effect of Dapagliflozin in Patients With Heart Failure and Reduced Ejection Fraction: Insights From the DAPA-HF Trial
David Burg, MD, MPH
Prognostic Significance of Hemodynamic Parameters in Patients With Cardiogenic Shock
David Burg, MD, MPH
Natural Language Processing for Adjudication of Heart Failure in the Electronic Health Record
Young Investigator Award Finalist
Distinguished Mentoring Award
Marcelo F. DiCarli, MD, Recipient
Improving Adherence: The Promise of Fixed-dose Combination Therapies
The Polypill to Reduce Global Cardiovascular Disease: Panacea or False Promise
Artificial Intelligence-assisted Cardiac MRI to Increase Diagnostic Quality, Consistency, and Patient Throughput at a High-Volume Program
Oral Presentation sponsored by Vista.ai
Artificial Intelligence-guided Cardiac Magnetic Resonance Imaging as a Clinical Routine Procedure Leads to Substantial Reduction of Scan Time and Improvement of Imaging Quality: Comparative Results of 1,147 Patient Studies From a Single U.S. Center
Session 1031, Theater 12, Hall F
Raymond Y. Kwong, MD, MPH, Michael Jerosch-Herold, PhD; Jon Mark Hainer, MD; Rhanderson Cardoso, MD; Nii Addy, PhD; Juan Santos, PhD; Lori Powell, MD; Bob S. Hu, MD
A Little VT Versus Sudden Cardiac Death at the Time of PVR, the ACHD Perspective
ACHD Family Feud
Learning By Doing, Immersive Simulation Experiences
Management of Arrhythmias in Advanced Heart Failure and Post-Transplant
Session 636: Ventricular Arrhythmias in the Transplanted Heart